cyflow cd4 minipoc system  (Partec)

Journal: BMC Infectious Diseases

Article Title: Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis

doi: 10.1186/s12879-016-1931-2

Figure Lengend Snippet: Characteristics and Quality assessment of studies included in the review

Article Snippet: For intervention (I), any of the following six commercially available POC CD4 testing platforms listed in the UNITAID “2014 HIV/AIDS Diagnosis Technology Landscape” report [ ] were included: (1) PointCare NOW™ (PointCare Technology Inc, Marlborough, MA, USA); (2) Pima™ CD4 (Alere Inc, Waltham, MA, USA); (3) Daktari™ CD4 Counter (Daktari Diagnostics Inc, Cambridge MA, USA); (4) CyFlow® CD4 miniPOC (Partec, Munich, Germany); (5) BD FACSPresto™ (BD Biosciences, San Jose, CA, USA); and (6) MyT4™ CD4 Test (Zyomyx Inc, Fremont, CA, USA).

Techniques: Infection, Flow Cytometry, Western Blot

Journal: BMC Infectious Diseases

Article Title: Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis

doi: 10.1186/s12879-016-1931-2

Figure Lengend Snippet: Performance of Pima stratified by venous and capillary blood collection and presented by reference test used

Article Snippet: For intervention (I), any of the following six commercially available POC CD4 testing platforms listed in the UNITAID “2014 HIV/AIDS Diagnosis Technology Landscape” report [ ] were included: (1) PointCare NOW™ (PointCare Technology Inc, Marlborough, MA, USA); (2) Pima™ CD4 (Alere Inc, Waltham, MA, USA); (3) Daktari™ CD4 Counter (Daktari Diagnostics Inc, Cambridge MA, USA); (4) CyFlow® CD4 miniPOC (Partec, Munich, Germany); (5) BD FACSPresto™ (BD Biosciences, San Jose, CA, USA); and (6) MyT4™ CD4 Test (Zyomyx Inc, Fremont, CA, USA).

Techniques: Flow Cytometry